HAE logo

HAE
Haemonetics Corp.

636
Mkt Cap
$2.98B
Volume
1.04M
52W High
$87.32
52W Low
$47.32
PE Ratio
32.23
HAE Fundamentals
Price
$65.49
Prev Close
$61.94
Open
$64.49
50D MA
$58.20
Beta
0.65
Avg. Volume
614,432.87
EPS (Annual)
$2.05
P/B
3.72
Rev/Employee
$443,345.63
$3,588.29
Loading...
Loading...
News
all
press releases
Haemonetics (HAE) Shares Cross Above 200 DMA
In trading on Friday, shares of Haemonetics Corp. (Symbol: HAE) crossed above their 200 day moving average of $62.24, changing hands as high as $65.84 per share. Haemonetics Corp. shares are currently trading up about 5.1% on the day. The chart below shows the one year perform...
News Placeholder
More News
News Placeholder
Investing in Haemonetics (HAE)? Don't Miss Assessing Its International Revenue Trends
Examine the evolution of Haemonetics' (HAE) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects.
News Placeholder
Is the Options Market Predicting a Spike in Haemonetics Stock?
Investors need to pay close attention to GBTG stock based on the movements in the options market lately.
News Placeholder
HAE Stock Gains on Q4 Earnings & Revenue Beat, Gross Margin Cut
Haemonetics beats Q4 EPS and revenue estimates, shares rise 1.4%, but gross margin falls 120 basis points as the company sets its FY27 growth outlook.
News Placeholder
Haemonetics Q4 Earnings Call Highlights
Haemonetics Q4 Earnings Call Highlights...
News Placeholder
Haemonetics (HAE) Q4 2026 Earnings Transcript
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
News Placeholder
Haemonetics (HAE) Reports Q4 Earnings: What Key Metrics Have to Say
Although the revenue and EPS for Haemonetics (HAE) give a sense of how its business performed in the quarter ended March 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
News Placeholder
Haemonetics (HAE) Q4 Earnings and Revenues Surpass Estimates
Haemonetics (HAE) delivered earnings and revenue surprises of +1.04% and +2.43%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
News Placeholder
Haemonetics Corporation Announces Fourth Quarter Fiscal 2026 Financial Results Available on Investor Relations Website
Haemonetics Corporation Announces Fourth Quarter Fiscal 2026 Financial Results Available on Investor Relations Website Haemonetics Corporation Announces Fourth Quarter Fiscal 2026 Financial Results Available on Investor Relations Website PR Newswire BOSTON, May 7, 2026 Financial release and...
News Placeholder
Envista (NVST) Surpasses Q1 Earnings and Revenue Estimates
Envista (NVST) delivered earnings and revenue surprises of +16.13% and +4.75%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
<
1
2
...
>

Compact View

Mini-Chart
Sentiment
Not available
Message Volume
Not available